Skip to Content

Ramsay Health Care Ltd ADR RMYHY

Morningstar Rating
$8.50 +0.44 (5.46%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

RMYHY is trading within a range we consider fairly valued.
Price
$8.07
Fair Value
$4.96
Uncertainty
High
1-Star Price
$22.42
5-Star Price
$8.60
Economic Moat
Zlqgwz
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if RMYHY is a good fit for your portfolio.

Trading Information

Previous Close Price
$8.06
Day Range
$7.988.50
52-Week Range
$7.3210.98
Bid/Ask
$7.83 / $8.80
Market Cap
$7.81 Bil
Volume/Avg
1,031 / 1,105

Key Statistics

Price/Earnings (Normalized)
49.30
Price/Sales
0.73
Dividend Yield (Trailing)
1.25%
Dividend Yield (Forward)
1.25%
Total Yield
1.29%

Company Profile

Ramsay Health Care is one of the largest private healthcare providers in the world, with over 460 facilities across 10 countries. The key markets in which it operates are Australia, France, the UK, and Sweden. It is the largest private hospital group in each of these markets except for the UK where it ranks fifth. Ramsay Sante, which operates the European regions other than the UK, is a 52.5%-owned subsidiary of Ramsay Health Care. The company typically earns about 60% of consolidated earnings in Australia and 30% in France. Ramsay Health Care undertakes both private and publicly funded healthcare.
Sector
Healthcare
Industry
Medical Care Facilities
Stock Style Box
Large Core
Total Number of Employees
88,000

Competitors

Valuation

Metric
RMYHY
SHL
THC
Price/Earnings (Normalized)
49.3024.8913.59
Price/Book Value
2.371.665.90
Price/Sales
0.731.520.48
Price/Cash Flow
11.1011.184.32
Price/Earnings
RMYHY
SHL
THC

Financial Strength

Metric
RMYHY
SHL
THC
Quick Ratio
0.760.781.10
Current Ratio
0.950.941.51
Interest Coverage
0.655.952.79
Quick Ratio
RMYHY
SHL
THC

Profitability

Metric
RMYHY
SHL
THC
Return on Assets (Normalized)
1.01%4.07%5.45%
Return on Equity (Normalized)
5.11%7.01%110.21%
Return on Invested Capital (Normalized)
1.26%4.52%11.10%
Return on Assets
RMYHY
SHL
THC
See how this stock stacks up to its competitors with Morningstar Investor

Medical Care Facilities Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
HCA
HCA Healthcare IncBytvmwjnHmlzr$84.4 Bil
FSNUY
Fresenius SE & Co KGaA ADRYtyyt$16.6 Bil
FSNUF
Fresenius SE & Co KGaARvjxmp$16.5 Bil
FMS
Fresenius Medical Care AG ADRHzpmTyhsmf$12.5 Bil
FMCQF
Fresenius Medical Care AGHprfkk$12.2 Bil
BDUUY
Bangkok Dusit Medical Services PCL ADRSfxc$12.0 Bil
DVA
DaVita IncPkssqzzvkKmbzfb$11.6 Bil
UHS
Universal Health Services Inc Class BTzjhv$11.1 Bil
THC
Tenet Healthcare CorpRrsvnfdkPchn$9.7 Bil
AMN
AMN Healthcare Services IncJlpttlfjkQyyxqc$2.2 Bil

Sponsor Center